Cleared Traditional

K896633 - AUTO-CUFF(TM)

K896633 is the FDA 510(k) clearance for AUTO-CUFF(TM) by U.S. Medical Corp.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K896633 · U.S. Medical Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1990
Decision
71d
Days
Class 2
Risk

K896633 is an FDA 510(k) clearance for the AUTO-CUFF(TM). Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by U.S. Medical Corp. (Cheshire, US). The FDA issued a Cleared decision on February 1, 1990 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all U.S. Medical Corp. devices

Submission Details

510(k) Number K896633 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 1989
Decision Date February 01, 1990
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 546
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K896633.
LOCAL REPORT GENERATOR
K904318 · Spacelabs, Inc. · Dec 1990
BIOCHEM 6100 NON-INVASIVE MONITOR
K903222 · Biochem International, Inc. · Sep 1990
FUKUDA DENSHI MODEL HJ-310
K901889 · Fukuda Denshi USA, Inc. · Jul 1990
SUPERMON NEONATAL NON-INVASIVE BLOOD PRESS. 7283
K882955 · Kontron Instruments, Inc. · Jan 1990
A&D AUTOMATIC DIGITAL BLOOD PRESSURE METER 2510/20
K895428 · A&D Engineering, Inc. · Nov 1989
A&D AUTOMATIC DIGITAL BLOOD PRESSURE METER 2650
K895429 · A&D Engineering, Inc. · Nov 1989